A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder
Clinical trial NCT03141086 · TERMINATED
Trial details
- NCT number
- NCT03141086
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2018-08-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.